| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |